{"database": "openregs", "table": "federal_register", "rows": [["E8-29688", "Guidance for Industry on Orally Disintegrating Tablets; Availability", "Notice", "The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled \"Orally Disintegrating Tablets.\" The guidance provides pharmaceutical manufacturers of new and generic products with an agency perspective on the definition of an orally disintegrating tablet (ODT) and also provides recommendations to applicants who would like to designate proposed products as ODTs.", "2008-12-16", 2008, 12, "https://www.federalregister.gov/documents/2008/12/16/E8-29688/guidance-for-industry-on-orally-disintegrating-tablets-availability", "https://www.govinfo.gov/content/pkg/FR-2008-12-16/pdf/E8-29688.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled \"Orally Disintegrating Tablets.\" The guidance provides pharmaceutical manufacturers of new and generic products with an agency perspective on the...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["E8-29688"], "units": {}, "query_ms": 0.31120888888835907, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}